Testing effectiveness (Phase 2)Looking for participantsNCT06385925
What this trial is testing
TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Who this might be right for
Malignant Neoplasm
Tyligand Pharmaceuticals (Suzhou) Limited 440